These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35760824)

  • 1. Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada.
    Isabel S; Abdulnoor M; Boissinot K; Isabel MR; de Borja R; Zuzarte PC; Sjaarda CP; R Barker K; Sheth PM; Matukas LM; Gubbay JB; McGeer AJ; Mubareka S; Simpson JT; Fattouh R
    Sci Rep; 2022 Jun; 12(1):10867. PubMed ID: 35760824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Point Mutations in the N Gene of SARS-CoV-2 Adversely Impact Detection by a Commercial Dual Target Diagnostic Assay.
    Miller S; Lee T; Merritt A; Pryce T; Levy A; Speers D
    Microbiol Spectr; 2021 Dec; 9(3):e0149421. PubMed ID: 34787486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleocapsid single point-mutation associated with drop-out on RT-PCR assay for SARS-CoV-2 detection.
    de Mello Malta F; Amgarten D; Marra AR; Petroni RC; da Silva Nali LH; Siqueira RA; Neto MC; Oler SC; Pinho JRR
    BMC Infect Dis; 2023 Oct; 23(1):714. PubMed ID: 37872472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant.
    Choi H; Hwang M; Lukey J; Jinadatha C; Navarathna DH
    Diagn Microbiol Infect Dis; 2022 Jul; 103(3):115699. PubMed ID: 35569431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    Lee J; Song JU
    J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Implementation of Improved SARS-CoV-2 Diagnostic Assays To Mitigate the Impact of Genomic Mutations on Target Failure: the Xpert Xpress SARS-CoV-2 Experience.
    Burns BL; Moody D; Tu ZJ; Nakitandwe J; Brock JE; Bosler D; Mitchell SL; Loeffelholz MJ; Rhoads DD
    Microbiol Spectr; 2022 Dec; 10(6):e0135522. PubMed ID: 36255326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of digital PCR to determine the reliability of Xpert Xpress SARS-CoV-2 assay with envelope (E) gene negative and nucleocapsid (N2) gene positive results.
    Wong RC; Wong AH; Ho YI; Siu GK; Lee LK; Leung EC; Lai RW
    Diagn Microbiol Infect Dis; 2022 Aug; 103(4):115726. PubMed ID: 35691105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection.
    Kami W; Kinjo T; Hashioka H; Arakaki W; Uechi K; Takahashi A; Oki H; Tanaka K; Motooka D; Nakamura S; Nakamatsu M; Maeda S; Yamamoto K; Fujita J
    J Virol Methods; 2023 Apr; 314():114692. PubMed ID: 36796678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
    Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification Failure by the Cepheid Xpert Xpress SARS-CoV-2 Assay due to a Single-Nucleotide Variant of the N Gene in the Omicron Variant.
    Shin S; Um TH; Cho CR; Chang J
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic.
    Peñas-Utrilla D; Sanz A; Catalán P; Veintimilla C; Alcalá L; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    BMC Microbiol; 2023 Jul; 23(1):190. PubMed ID: 37460980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests.
    Tieman BC; Kovacs S; Rodgers MA; Mohaimani A; Gregory S; Christensen D; Moore JA; Schurig-Briccio L; Hartnett J; Kar A; Leeman A; Palmer A; Rogers L; Dragoo B; Muszynski S; Noblesmith D; Gardner S; Snipe-Bushey A; Kill A; Luo X; Cherukuri S; Rae T; Marohnic CC; Cloherty GA; Muerhoff AS; Hemken PM
    Biotechniques; 2022 Sep; 73(3):136-141. PubMed ID: 36004516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 N Gene G29195T Point Mutation May Affect Diagnostic Reverse Transcription-PCR Detection.
    Ko KKK; Abdul Rahman NB; Tan SYL; Chan KXL; Goh SS; Sim JHC; Lim KL; Tan WL; Chan KS; Oon LLE; Nagarajan N; Suphavilai C
    Microbiol Spectr; 2022 Feb; 10(1):e0222321. PubMed ID: 35019683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay.
    Khoshchehreh M; Wald-Dickler N; Holtom P; Butler-Wu SM
    J Clin Virol; 2020 Dec; 133():104683. PubMed ID: 33142250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
    Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
    J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline.
    Kuchinski KS; Jassem AN; Prystajecky NA
    J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
    Wollschläger P; Todt D; Gerlitz N; Pfaender S; Bollinger T; Sing A; Dangel A; Ackermann N; Korn K; Ensser A; Steinmann E; Buhl M; Steinmann J
    Clin Microbiol Infect; 2021 Sep; 27(9):1353.e1-1353.e5. PubMed ID: 34044153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.